A University of Adelaide-led team of scientists has suggested a potential link between iron in our cells and the rare gene mutations that cause Alzheimer's disease, which could provide new avenues for future research.
An international panel of 11 clinical and research experts from around the world reviewed the most current pharmacological and non-pharmacological treatment recommendations for these symptoms in people with Alzheimer’s disease.
A Raleigh start-up that has created an AI-based system to collect data and offer advice on the treatment of early-stage Alzheimer’s disease says it’s now working to expand the number of clinics it works with.
The portal for the National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (NIAGADS) is currently undergoing beta testing involving a small number of investigators, with broader access slated to begin next month.
Though mental decline can be an uncomfortable topic for patients and their doctors, the panel says family physicians should do a thorough evaluation when concerning symptoms arise and share the diagnosis candidly.
A new report from top researchers says the number of drugs advancing through clinical phase two and phase three trials provides reason to believe that breakthroughs may be in the current pharmaceutical pipeline.